Zogenix (ZGNX)

[THREE-DAY-TRADER]

As per your 'Q' at other board...
I have not been paying particular attention to ZGNX lately, but am aware of it and have in recent past liked it on dips such as last December.
But regardless of what I may think of chances for their FDA review upcoming it really is not the full point.
My experience with these biotechs is usually do not be long them right before FDA announcement because FDA is a gamble and hard to predict.
Buy on dips before hand and sell the gap ups preferably leading up to FDA dates (such accumulation leading up to it in past few weeks), or play the sales on other news item catalysts that 'pop' the stock after buying on big capitulative down days.

Otherwise, the only other strategy I would apply on playing the FDA dates (if confidence is very high FDA will approve), is holding some shares before the PDUFA ruling only if you had owned it in weeks past at lower price on 'the dip', that way if FDA does not approve, then your risk is reduced rather than buying right before the FDA ruling date.
Additionally, if you had bought in lower 1's a few weeks back, you could sell some (half?) shares right before the decision to lock in some profits and hedge risk in case FDA says no to ZGNX, but still you have some benefit if FDA affects ZGNX to the upside.

Hope this helps.
Take care.

(FYI--- I'm a free acct here, so I only have 15 posts per day and I do not send PM's.